GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (OTCPK:ELVAF) » Definitions » EV-to-EBITDA

Evolva Holding (Evolva Holding) EV-to-EBITDA : -0.22 (As of May. 03, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Evolva Holding EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Evolva Holding's enterprise value is $21.18 Mil. Evolva Holding's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-95.14 Mil. Therefore, Evolva Holding's EV-to-EBITDA for today is -0.22.

The historical rank and industry rank for Evolva Holding's EV-to-EBITDA or its related term are showing as below:

ELVAF' s EV-to-EBITDA Range Over the Past 10 Years
Min: -23.94   Med: -5.09   Max: -0.22
Current: -0.22

During the past 13 years, the highest EV-to-EBITDA of Evolva Holding was -0.22. The lowest was -23.94. And the median was -5.09.

ELVAF's EV-to-EBITDA is ranked worse than
100% of 466 companies
in the Biotechnology industry
Industry Median: 9.15 vs ELVAF: -0.22

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-03), Evolva Holding's stock price is $1.10. Evolva Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-22.767. Therefore, Evolva Holding's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Evolva Holding EV-to-EBITDA Historical Data

The historical data trend for Evolva Holding's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding EV-to-EBITDA Chart

Evolva Holding Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.65 -10.32 -7.39 -4.19 -2.94

Evolva Holding Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -4.19 - -2.94 -

Competitive Comparison of Evolva Holding's EV-to-EBITDA

For the Biotechnology subindustry, Evolva Holding's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolva Holding's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Evolva Holding's EV-to-EBITDA falls into.



Evolva Holding EV-to-EBITDA Calculation

Evolva Holding's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=21.177/-95.138
=-0.22

Evolva Holding's current Enterprise Value is $21.18 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evolva Holding's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-95.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Evolva Holding  (OTCPK:ELVAF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Evolva Holding's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.10/-22.767
=At Loss

Evolva Holding's share price for today is $1.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Evolva Holding's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $-22.767.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Evolva Holding EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Evolva Holding's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolva Holding (Evolva Holding) Business Description

Traded in Other Exchanges
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding (Evolva Holding) Headlines

From GuruFocus

Half Year 2023 Evolva Holding SA Earnings Call Transcript

By GuruFocus Research 02-13-2024